The present invention relates to Coronavirus 2019-nCoV spike protein, polynucleotides encoding said spike protein, antibodies and vaccines for treatment or prevention of 2019-nCoV infection. One embodiment refers to isolated polynucleotide encoding a spike protein from 2019-nCoV having at least 90% identity with SEQ...

The present invention focuses on gene therapy and genetic vaccines, utilizing untranslated regions (UTRs) to enhance post-transcriptional protein and peptide translation within mammalian cells. Furthermore, it introduces synthetic 5' UTRs, allowing precise control of gene expression and the methodology involves mR...